Henrik Mordhorst
Directeur Financier/CFO chez SERODUS ASA
Postes actifs de Henrik Mordhorst
Sociétés | Poste | Début | Fin |
---|---|---|---|
SERODUS ASA | Directeur Financier/CFO | 01/01/2019 | - |
HeMo ApS | Directeur Général | 01/09/2015 | - |
Fondateur | 01/09/2015 | - |
Historique de carrière de Henrik Mordhorst
Anciens postes connus de Henrik Mordhorst
Sociétés | Poste | Début | Fin |
---|---|---|---|
Agrofond A/S | Directeur Général | 01/09/2013 | 01/08/2015 |
Fondateur | 01/09/2013 | 01/08/2015 | |
Colony Denmark ApS
Colony Denmark ApS Packaged SoftwareTechnology Services Colony Denmark ApS provides interactive software for the television industry. Its products include Wallbreaker Platform, Pollmaker Suite, Pollbreaker, Mediamaker Suite, and Gamemaker Suite. The company was founded by Martin Kløft and Mikkel Strøbech in 2014 and is headquartered in Copenhagen, Denmark. | Directeur/Membre du Conseil | - | - |
Directeur Financier/CFO | - | - |
Formation de Henrik Mordhorst
Copenhagen Business School | Graduate Degree |
Statistiques
Internationale
Danemark | 5 |
Norvège | 2 |
Opérationnelle
Director of Finance/CFO | 2 |
Chief Executive Officer | 2 |
Founder | 2 |
Sectorielle
Technology Services | 2 |
Health Technology | 2 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 4 |
---|---|
Colony Denmark ApS
Colony Denmark ApS Packaged SoftwareTechnology Services Colony Denmark ApS provides interactive software for the television industry. Its products include Wallbreaker Platform, Pollmaker Suite, Pollbreaker, Mediamaker Suite, and Gamemaker Suite. The company was founded by Martin Kløft and Mikkel Strøbech in 2014 and is headquartered in Copenhagen, Denmark. | Technology Services |
Serodus ASA
Serodus ASA BiotechnologyHealth Technology Serodus ASA is a bio-medical company, which engages in the development of medicines for the treatment of diabetes related complications. It focuses on diabetic kidney disease, diabetic retinopathy, type 1 diabetes, and diabetic foot ulcers. The company was founded by Finn Olav Levy on January 21, 2008 and is headquartered in Oslo, Norway. | Health Technology |
Agrofond A/S | |
HeMo ApS |
- Bourse
- Insiders
- Henrik Mordhorst
- Expérience